Annette Tumolo - Sep 2, 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Executive Vice President
Signature
/s/ Annette Tumolo
Stock symbol
BIO
Transactions as of
Sep 2, 2021
Transactions value $
-$123,866
Form type
4
Date filed
9/3/2021, 05:10 PM
Previous filing
Aug 27, 2021
Next filing
Sep 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +433 +13.97% $0.00 3.53K Sep 2, 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$124K -150 -4.25% $825.77 3.38K Sep 2, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -433 -24.99% $0.00 1.3K Sep 2, 2021 Bio-Rad A Common Stock 433 $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.